Home

Eurocine Vaccines AB

Eurocine Vaccines operates in the pharmaceutical industry with a focus on developing vaccines for the global market. The company develops vaccine candidates from early innovation and licenses them to partners for further development and commercialization. The activities are carried out in the bioscience cluster at Karolinska Institutet in Solna, Sweden.

Quotes for Eurocine Vaccines AB

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Hans Arwidsson

Chairperson of the Board

  • Pierre Morgon

Board

  • Carlos von Bonhorst
  • Emanuele Montomoli
  • Hans Arwidsson
  • Pär Thuresson
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Videos

    Eurocine Vaccines - Annual Review 2021

    Origin of the Chlamydia Vaccine

    Sitdown - Eurocine Vaccines

    Largest Owners

    Name Capital % Votes % Date
    Thomas Eldered 28,68 28,68 2022-12-28
    Avanza Pension 5,93 5,93 2022-12-28
    Nordnet Pensionsförsäkring 2,10 2,10 2022-12-28
    Kent Olsson 1,43 1,43 2022-12-28
    Göran Erlandsson 1,28 1,28 2022-12-28
    Mats Kenneth Pettersson 1,01 1,01 2022-12-28
    Bo Sjögren 0,85 0,85 2022-12-28
    VisMederi Srl 0,79 0,79 2022-10-20
    Stig Andreas Lööf 0,78 0,78 2022-12-28
    Johann Bech Vedsmand 0,74 0,74 2022-12-28
    ** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

    Insider trading

    Key Numbers

    *Compiled data from Millistream

    Upcoming reports

    • 2023-05-24 Delårsrapport 2023-Q3

    • 2023-08-30 Bokslutskommuniké 2023

    Annual reports, prospectus etc.

    Technical analysis

    EUCI- 2019-02-04

    Technical analysis

    EUCI- 2018-12-03

    Technical analysis

    EUCI- 2018-11-19

    Technical analysis

    EUCI- 2018-06-14